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 Abstract 
Background: The heart is unable to regenerate its tissues after severe injuries. Stem cell therapy 
appears to be one of the most promising approaches, though preclinical results are hitherto 
contradictory and clinical trials scanty and/or limited to phase-I. The limited knowledge about 
stem cell early homing in infarcted cardiac tissues can concur to this scenario. 
Methods: the stem cell migration was assessed in in-vitro and ex-vivo models of heart ischemia, 
employing a rat dental pulp stem cell line (MUR-1) that shares the same ontogenic progenitors 
with portions of the heart, expresses markers typical of cardiac/vascular-like progenitors and is 
able to differentiate into cardiomyocytes in-vitro. 
Results: Here, we demonstrated that the MUR-1 can reach the injured cells/tissue and make 
contacts with the damaged cardiomyocytes, likely through connexin 43, N-cadherin and von 
Willebrand Factor mediated cell-cell interactions, both in in-vitro and ex-vivo models. 
Furthermore, we found that SDF-1, FGF-2 and HGF, but not VEGF are involved as chemotactic 
factors in MUR-1 migration, notifying a similarity with neural crest cell behavior during the 
organogenesis of both the splancnocranium and the heart. 
Conclusions: herein we found a similarity between what happens during the heart organogenesis 
and the early migration and homing of MUR-1 cells in ischemic models. 
General significance: The comprehension of molecular aspects underlying the early phases of stem 
cell migration and interaction with damaged organ contributes to the future achievement of the 
coveted stem cell-mediated organ regeneration and function preservation in-vivo. 
 
 
 
Highlights 
 MUR-1 dental pulp stem cells migrate towards injured cardiomyocytes 
 MUR-1 cells make contact with cardiomyocytes by means of Connexin 43 and N-cadherin 
 MUR-1 cells adhere to injured cardiomyocytes by means of von Willebrand Factor 
 MUR-1 cells are responsive to SDF-1, FGF-2 and HGF but not VEGF chemotaxis 
 
 
1. Introduction 
  
Adult stem and progenitor cells present throughout the body may replace dying cells and 
reconstitute injured tissues, thus preserving organs and whole organism homeostasis. However, 
they are generally unable to guarantee enough regeneration after severe damage. For instance, 
myocardial infarction results in a massive cardiomyocyte (CM) loss due to apoptosis and necrosis, 
which is followed by CM replacement with stiff non-contractile scar tissue frequently inducing 
ventricular remodeling and organ failure [1-4]. Since the injured mammalian adult heart has an 
intrinsic limited capability to regenerate myocardium several approaches have been proposed to 
prevent or treat heart failure. These include: (i) delivery of factors aimed at stimulating the 
repairing ability of resident cardiac stem cells; (ii) reprogramming non-muscle cells (e.g. 
fibroblasts) into CMs; (iii) identification, manipulation and implantation of stem or progenitor cells 
[5-7]. Although these strategies are promising, they do not achieve cardiac regeneration sufficient 
to restore function of a failing heart and are still far from replacing classical non-resolutive 
strategies (rational use of drugs and heart transplantation) [8]. 
Observation that mesenchymal stem cells (MSCs) of both homo- and hetero-topic origins can 
differentiate in-vitro towards cardiac lineage [6, 9-11] provoked increasing interest and 
perspective about the possibility to restore damaged myocardium with MSCs. Since cells 
“implanted in” or “delivered to” the target site may frequently vanish within few days, some 
Authors support the hypothesis that MSCs promote positive actions in terms of cardiac 
functionality due to production of trophic factors, induction of vasculogenesis, and differentiation 
into CM [5, 6]. However, the extent of stem cell-induced myocardial repair has not yet been 
defined, as the preclinical results are controversial and the clinical experimentations are still in 
progress or almost limited to phase-I trials [6, 12-14]. In this point of view, local and systemic 
administrations of different MSCs hitherto resulted in poor improvement of cardiac function [6, 
15].  
The exegesis of these controversial results remains still unclear. Anyhow, molecular and biological 
data about MSC early homing in cardiac tissue are scarce or frequently absent; MSCs are reported 
to display a limited plasticity in the differentiation process towards a functional contractile 
phenotype [16]; finally, the heterogeneity in MSC derivation, antigen expression, together with 
the differences in isolation and expansion protocols, further contributed to complicate the 
comprehension and integration of the available data.  
In this context, our group recently isolated, identified and characterized a MSC line from rat dental 
pulp (MUR-1), a tissue directly derived from the neural crest, and hence featuring peculiar 
characteristics [17]. This cell line can be propagated and passaged for long time in a feed-
layer/supplement-free culture without any signs of neoplastic transformation and spontaneous 
differentiation or alterations in geno- and pheno-type, clonogenicity, self-renewal and potency. In-
vitro, MUR-1 cells were seen to differentiate (under appropriate stimulations) not only into 
adipogenic, osteogenic, chondrogenic lineages, but also toward neurogenic and cardiomyogenic 
lineages. Importantly, in the last case, MUR-1 cells demonstrated the appearance of a properly 
organized α-sarcomeric actinin. Moreover, MUR-1 cells constitutively express markers typical of 
cardiac/vascular-like progenitors, such as c-Kit, Endoglin, Flk1, Nkx-2.5, Mef2c, Gata4, ADRB2, and 
CX43, together with several stemness markers typically depicting the undifferentiated 
mesenchymal or an even less differentiated/embryonic-like status (e.g. CD90, c-Myc, Oct4, SSEA1, 
Fragilis1, Stella and YAP1). 
Based on the above findings, we hypothesized that MUR-1 might sense signals from injured CMs 
and migrate towards them. Therefore, the aim of the present study is to improve the knowledge 
on the potential early homing of dental pulp stem cells in infarcted hearts. Both in-vitro and ex-
vivo model were used to assess the behavior of these cells and to identify the involved 
chemotactic factors. 
 2. Materials and methods 
2.1. Cell culture and in-vitro damage assessment on cardiomyocytes 
MUR-1 rat dental pulp stem cell line was previously established [17] and stored in our laboratory. 
The embryo rat cardiomyocyte (H9c2) cell line was a generous gift from Dr. Claudia Penna 
(University of Turin). Both cell lines were standardly cultured in 75 cm2 TPP® flasks (TPP Techno 
Plastic Products AG, Trasadingen, Switzerland) in RPMI-1640 medium (PAA Laboratories GmbH, 
Cölbe, Germany) supplemented with 10% fetal calf serum (FCS) (PAA Laboratories GmbH), 100 
U/ml penicillin G, 40 μg/ml gentamicin sulfate and 2,5 μg/ml amphotericin B at 37°C in a 
humidified 5% CO2 atmosphere.  
H9c2 cells were plated at the density of 5x104/well in 96-well plates (Becton Dickinson Labware, 
BD Italia, Buccinasco, Milano, Italy). After one day, cells underwent one of the following injuring 
protocols: (i) 24h-lasting 1% O2 hypoxia in an “Invivo2-200” hypoxic chamber (Ruskinn Technology 
Ltd, Pencoed, UK); (ii) 24h-lasting serum deprivation; (iii) a combination of both [18]. Untreated 
H9c2 were used as control. H9c2 viability was assessed after the injury by 3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) [19]. Briefly, MTT was added to growth medium 
(final concentration 0.5 mg/ml) and cells were further cultured for 3 h in normal condition. 
Medium was then replaced with equal volume of dimethyl sulfoxide to lyse cells. The MTT 
absorbance was read at 560 nm with an Asys UVM-340 microplate reader (Biochrom, Cambridge 
Science Park, Cambridge, UK). MTT data were expressed as percentage of the control (standard 
culture condition). Experiments were performed in triplicate. 
 
2.2. MUR-1 migration assay 
MUR-1 migration ability was assessed in 8 μm pore-sized transwell inserts (Boyden chambers, 
Becton Dickinson Labware, Franklin Lakes, NJ, USA). Briefly, H9c2 were plated in 24-well plates 
and damaged as describe above. At the end of injury induction, a transwell insert seeded with 
8x104 MUR-1 cells was added to each H9c2 containing well. Migration was allowed for 24 h in 
serum-free normal-oxygen condition allowing H9c2 cells to release/secrete post-damage 
chemotactic factors. Medium additioned with 30% FBS was used as positive control of maximum 
migration potential, while serum-free medium was used as negative control [20]. After the 24 h 
incubation, transwell inserts were removed, gently washed and fixed in 2.5% glutaraldehyde. To 
quantify migration, transwell inserts were stained with crystal violet and four randomly chosen 
fields were photographed with an Eclipse TS100 microscope coupled with a DS-L1 camera control 
unit (Nikon Instruments S.p.A, Firenze, Italy). Color intensity was gathered with ImageJ software 
(http://imagej.nih.gov/ij). Migration ability was expressed as fold changes of negative control. 
Each experiment, consisting of two transwell inserts for each condition, was done in triplicate. 
 
 
2.3. MUR-1 adhesion assay 
Adhesiveness of MUR-1 cells on H9c2 feeder was assessed as previously described [21] with some 
modifications. Sub-confluent MUR-1 were harvested with trypsin-EDTA solution (PAA Laboratories 
GmbH), rinsed twice with phosphate buffer saline (PBS), and resuspended in a PBS solution 
containing 2.5 μM carboxyfluorescein diacetate succinimidyl ester (CFDA-SE, Sigma-Aldrich) under 
continuous stirring for 15 min. After labeling, cells were rinsed twice in PBS and resuspended in 
RPMI-1640 supplemented with 5% FCS. Confluent H9c2 cells grown on 96-well plates (Becton 
Dickinson Labware) underwent 24h-lasting serum deprivation. Undamaged H9c2 cells were used 
as control. Before assay, injured and control H9c2 were rinsed once with Hank’s balanced solution 
(HBSS) and left in 50 μl HBSS. Labeled MUR-1 at 1x104/50 μl density were added to H9c2 cells and 
incubated for 30 min at 37°C and 5% CO2. After incubation, each well was washed twice with PBS, 
fixed in 4% paraformaldehyde and bound MUR-1 cells were imaged in fluorescence and counted. 
The same experiment was also performed in 8-well chamber-slides (Lab-Tek, Thermo Fischer 
Scientific Inc., Waltham, MA, USA) in order to assess the involvement of connexin-43 (CX43), N-
cadherin (N-CAD) and von Willebrand factor (vWF) in MUR-1 adhesiveness. Slides were incubated 
with specific primary antibodies overnight at 4°C and then with appropriate secondary antibodies 
for 1 h at room temperature. The used antibodies and dilutions are reported in Table 1. Image 
acquisition of specific antigenic expression was carried out with a TCS SP5 confocal laser 
microscopy system (Leica Microsystem S.r.l., Milano, Italy). Each experiment was done in 
triplicate. 
 
2.4. Hearts isolation 
Hearts were isolated as previously described [22]. Briefly, 10 min after heparin injection (200 IU, 
i.m., Roche, Milan, Italy), five month-old Wistar rats (male, n=15, Harlan-Italy, San Pietro al 
Natisone, Italy) were anesthetized (ketamine 100 mg/kg and xylazine 5 mg/kg) and sacrificed.The 
hearts were rapidly excised and placed in ice-cold Krebs–Henseleit (KH) buffer supplemented with 
5 g/ml 10 mg/ml xylocaine to prevent the appearance of arrhythmias. Then they were suspended 
to a Langendorff apparatus and retrogradely perfused via aorta at constant flow with KH buffer in 
a non-recirculating way. The perfusate buffer was saturated with 95% O2 and 5% CO2 gas mixture 
and infused at 37°C. The coronary flow was adjusted with a constant flow perfusion pump 
(Watson-Marlow 505DU, Falmouth, Cornwall, UK) to obtain a level of 9 ml/min/g corresponding to 
a perfusion pressure of about 80-85 mmHg during the stabilization period. 
 
2.5. MUR-1 engraftment 
 
MUR-1 cells were engrafted following the protocol of Penna et al [23], with some modifications. 
Briefly, sub-confluent MUR-1 cells were harvested with 0.25% trypsin solution (Sigma-Aldrich) and 
added of complete medium. Cells were CDFA-SE-labeled as above described, resuspended in PBS 
at 1x106/300μl density and implanted in the apex (area not interested by ischemia) of isolated 
hearts from both control (Ctrl, n=7) and ischemia/reperfusion (I/R, n=8) groups. In Ctrl, MUR-1 
cells were injected after 55 min of stabilization. In I/R group, after 20 min of stabilization, the 
infarction was obtained by ligation of the left anterior descendent coronary artery proximally to 
the origin of the left circumflex artery. After 30 min, the occlusion was removed and MUR-1 cells 
were implanted after 5 min of reperfusion. After the engraftment, hearts of both groups were 
perfused for 4 h and then removed from the Langendorff’s apparatus.  
Three hearts randomly chosen from each group were stained with trypan blue to assess extension 
of ischemic areas. Twenty ml of trypan blue 1:500 in PBS were infused into the aorta at 150 ml/h 
rate and then washed with an equal volume of PBS using a syringe pump (STC 31521 Terumo Inc., 
Tokyo, Japan). All the hearts were fixed in 4% paraformaldehyde and OCT (Tissue-Tek® 
O.C.T.Compound, Sakura Finetek Europe B.V., Zoeterwoude, Netherlands) embedded for the 
histological analyses. 
 
2.6. Histological analyses  
Ten micrometers thick sections were obtained cutting the whole heart starting from the apex. All 
sections were observed with LSM 510 laser confocal microscopy system (Zeiss, Jena, Germany) to 
study the early homing of the green CFDA-SE labeled MUR-1. For each heart, the volume of 
myocardium where MUR-1 cells migrated (volume of migration) was calculated as the sum of four 
different pyramidal frustum volumes. Briefly, it was obtained gathering the areas circumscribed by 
MUR-1 cells in 5 equidistant sections (ranging from the lowest to the highest section in which 
MUR-1 cells were detected) and applying the formula: 
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where Bi and Bi+1 represent the bottom and the top base area, respectively and hi represents the 
perpendicular height from the bottom to the top area which is calculated from the number of 
slices interposed between the two frustum bases.  
Sections from each heart were stained for CX43, N-CAD and vWF, as described above.  
 
2.7. MUR-1 characterization for involved chemotactic receptor 
Expression of chemotactic factor receptors was assessed by immunocytochemical analyses. MUR-
1 cells were cultured on poly-D-lysine-coated coverslips and then stained as described above. The 
used antibodies and dilutions are reported in Table 1. Image acquisition of specific antigen 
expression was carried out with a TCS SP5 confocal laser microscopy system (Leica Microsystem 
S.r.l.).  
The involvement of each chemotactic receptor in MUR-1 migration was assessed by means of 
Boyden chambers. Transwell inserts seeded with 8x104 MUR-1 cells were added to wells 
containing SDF-1 (50-1500 ng/ml), VEGF (1-500 ng/ml), FGF-2 (10-200 ng/ml) or HGF (20-500 
ng/ml) in serum-free medium. All factors were kindly supplied by ImmunoTools, Friesoythe, 
Germany (see acknowledgments). After 24 h, transwell inserts were processed and migrations 
quantified as described above. Each experiment, consisting of two transwell inserts for each 
condition, was done in triplicate. 
 
2.8. Statistical analysis 
Differences among cell viabilities were assessed with two-way ANOVA and Bonferroni post-test. 
One-way ANOVA and Newman–Keuls multiple comparison test (for post-ANOVA comparisons) 
were used to evaluate the statistical significance of the differences in cell migration in-vitro and 
ex-vivo. Two-tailed Student’s t-test was used to evaluate MUR-1 adhesiveness on H9c2 cells. All 
data are graphicated as box plot and analyzed with GraphPad Prism version 5.00 (GraphPad 
Software, San Diego California USA, http://www.graphpad.com), with P<0.05 as the significance 
cut off. 
 3. Results 
3.1. Chemotactic action of injured H9c2 on MUR-1 
Similarly to what previously described by Bonavita et al [18], H9c2 cell viability was greatly 
hampered (P<0.001) by either serum deprivation (42.97±9.51%) or oxygen reduction 
(68.97±12.65%) with respect to standard culture condition (100±15.72%). Serum deprivation had a 
higher impact on cell viability if compared with oxygen reduction (P<0.001). In this context, the 
concomitant treatment with serum deprivation and oxygen reduction induced a slight worsening 
of H9c2 cell viability (35.46±3.16%) when compared to the serum-free condition alone (P<0.05). 
MUR-1 migration ability toward H9c2 injured by serum deprivation either with or without hypoxia 
was assessed. After 24 h incubation, injured H9c2 were able to induce a 2-fold MUR-1 migration 
ability relative to the negative controls (P<0.001). In particular, the hypoxic condition induced a 
15.94% increase in migration ability with respect to the normoxic one (2.33-fold vs 2.01-fold, 
P<0.01). In the positive control a 5-fold migration ability was observed (P<0.001, Fig. 1A).  
 
3.2. Injured H9c2 cells enhance MUR-1 adhesion  
We assessed whether MUR-1 cells could adhere to H9c2 feeder and whether this adhesiveness 
could change in response to the starvation-mediated injury. MUR-1 cells adhered to H9c2 cells in 
both control and injuring conditions (Fig. 1B), but the H9c2 serum starvation induced an increment 
of adhesion (+81.7%) with respect to the control (591.2±46.20 MUR-1/well vs 325.4±58.19 MUR-
1/well, P<0.01). Since CX43, N-CAD and vWF are involved in cell adhesion [21, 24-28], we 
evaluated their localization on the MUR-1 (identifiable for their green labeling with CFDA-SE), 
which adhere to H9c2 cells. CX43 was found between MUR-1 and H9c2 in both control and injury 
conditions (Fig. 1C-D). Interestingly, MUR-1 appeared generally round-shaped in the former case 
and more elongated through the injured CMs in the latter. Similarly, N-CAD appeared expressed in 
both conditions (Fig. 1E-F). Unlike what observed for CX43 and N-CAD, vWF localization on MUR-1 
was greatly affected by H9c2 serum starvation-mediated injury. In fact, while in the control vWF 
was predominantly confined into the H9c2 and MUR-1 cell cytoplasm (Fig. 1G), in the injured 
tissue it was mainly located on the membranes, suggesting an involvement in the setting-up of 
focal adhesion between MUR-1 and injured H9c2 cells (Fig. 1H). 
  
3.3. Behavior of MUR-1 cells in normal and infarcted hearts 
To confirm the tropism displayed by MUR-1 in response to chemotactic stimuli produced by 
injured CMs, their migration was tested in an ex-vivo ischemic heart model. CDFA-SE-labeled MUR-
1 cells were injected into the apex of the hearts. Indeed, at the histological observation MUR-1 
appeared stained in bright-green, which allowed their recognition and localization within the 
myocardium.   
In I/R hearts, MUR-1 cells greatly spread throughout the left ventricle tissue, whereas they formed 
clusters in the Ctrl (Fig. 2A-D). Furthermore, MUR-1 cells can be detected in 344±52 and 227±19 
10µm-thickned serial slices in the I/R and Ctrl hearts, respectively (P<0.001). Hence, great 
differences were present between the two groups in terms of MUR-1 migration: the migration 
volumes in 3-D reconstructed hearts were 18.04±11.45 mm3 and 3.04±0.88 mm3 in I/R and Ctrl, 
respectively (P<0.05, Fig. 2E). Moreover, the volume of MUR-1 migration corresponded to the 
extension of ischemic damage within tissues, as shown by the co-localization of MUR-1 cells with 
injured area highlighted by trypan blue staining (Fig. 2F-G).  
 
3.4. Immunohistochemical analysis of MUR-1 cell early homing in the cardiac tissue 
As MUR-1 cells express CX43 [17], N-CAD and vWF which are involved in MUR-1 adhesiveness in-
vitro (as described in the paragraph 3.2), their cellular localization was analyzed also after ex-vivo 
implantation. CX43 localization changed in response to ischemic condition. Indeed, in Ctrl hearts 
(Fig. 3A-B) it was mainly present amidst MUR-1 cells allowing clusters formation, while in I/R 
tissues (Fig. 3C-G), CX43 was present between the two histotypes allowing MUR-1 cells to keep 
contact with the host fibers. N-CAD seems to have a similar pattern of expression (Fig. 3H-J); in 
fact CX43 and N-CAD are predominantly co-localized, although this phenomena appears more 
evident in I/R hearts than in the CTRL (Fig. 4). Finally, vWF was nearly absent in Ctrl hearts (Fig. 5A-
B) except for vessels (not shown), but it was detectable as spots in I/R tissues, where it mainly co-
localized with MUR-1 cells (Fig. 5C-F).  
 
3.5. Identification of the major chemotactic factors involved in MUR-1 migration 
To identify the stimuli involved in MUR-1 migration, we assessed the expression of membrane 
receptors specific for chemotactic factors and the migratory effects of the latter in a Boyden 
chamber assay.  
Immunocytochemistry highlighted the presence of the SDF-1 receptor (CXCR4), fibroblast growth 
factor receptor 1 (FGFR1), hepatocyte growth factor receptor (c-MET) and vascular endothelial 
growth factor receptor 1 (Flt-1) (Fig. 6A) in MUR-1 cells.  
When the migration of MUR-1 cells in response to soluble factors was analyzed in Boyden 
chambers, SDF-1 was found to induce migration only at 500 ng/ml (Fig. 6B1; P<0.05) and FGF-2 
only at 50 ng/ml (Fig. 6B2; P<0.05), respectively, but neither at lower nor higher concentrations. 
The level of migration was comparable for the two factors (P=0.76). HGF stimulated migration at 
all evaluated concentrations in a dose-dependent relationship (Fig. 6B3; P<0.05). A hundred ng/ml 
HGF mediated the same effect displayed by 500 ng/ml SDF-1 or 50 ng/ml FGF-2 (P=0.28 and 
P=0.15, respectively). At higher concentrations (250 and 500 ng/ml) the migratory response was 
even higher (P<0.001). On the contrary, VEGF did not induce migration in MUR-1 cells at any of the 
evaluated concentrations (Fig. 6B4).  
 
 4. Discussion 
 
Here we report that the MUR-1 dental pulp stem cells are attracted by injured CMs in both in-vitro 
and ex-vivo models. Thus, in an experimentally infarcted heart, they migrate to the injured 
myocardium from a remote (non-ischemic) site of injection. The in-vitro experiments suggested 
that MUR-1 migration depends on the expression on their membrane of functional receptors for 
different growth factors, namely SDF-1, FGF-2, and HGF, which are generally released by the 
injured myocardium [29-34]. 
Since ischemic injuries of the heart are characterized by the loss of contractile cells and so far 
there are not definitive pharmacological/procedural treatments [2, 8], the possibility of a cell 
based therapy aiming at replacing the apoptotic and necrotic CMs could greatly enhance both 
expectancy and quality of patients’ life. Unfortunately, cell-therapy still lacks consistent results in 
clinical trials although sometimes promising ones have been obtained [6, 12-15, 35].  
It is accepted that the heart contains some stem/progenitor cells, which are responsible for the 
maintenance of the organ homeostasis. Although recently some Authors demonstrated the 
presence of c-Kit+ cardiac stem cells able to mediate cardiac regeneration and repair in rodents 
[36, 37], resident cardiac stem cells are insufficient or inadequate to repair a severely injured 
heart [38]. The possibility to recruit multipotent cells within the organism can thus be an option 
[6]. The present study was planned to unravel some still elusive and debated aspects of stem cell 
early homing in the heart after ischemic lesion. We employed the MUR-1 dental-pulp rat stem line 
due to its c-Kit+/Nkx-2.5+/Mef2c+/Gata4+/CX43+/Flk1+/Endoglin+/CD34-/CD45- phenotypic profile 
[17] that is comparable to those of some cardiomyocyte progenitor cells [39, 40] and because of 
its capability (under appropriate stimuli) to differentiate into cardiomyocyte lineage in-vitro, as 
previously described [17] and here confirmed (data not shown). Furthermore, we considered that 
teeth (and more in general splanchnocranium structures) share a common neural crest origin with 
some parts of the heart [24, 41, 42]. In addition, here we demonstrated that MUR-1 cells 
constitutively express also N-CAD and vWF, two important factors for cardiac and vessel 
homeostasis and function [28, 43]. 
Our results showed that the H9c2 CM line, experimentally injured by hypoxia and/or serum 
deprivation [18], prompted MUR-1 cells migration. Furthermore, the serum starvation of H9c2 
cells enhanced the MUR-1 adhesiveness, which seems to be based on CX43- and N-CAD-mediated 
intercellular interactions and vWF-mediated focal adhesions, as already reported for other cell 
types [21, 24-28]. Since motility and adhesiveness of MUR-1 cells were responsive to H9c2 cell 
injury in-vitro, we focused our attention on their homing in an ex-vivo model of ischemic rat heart. 
In this context, it was already shown that MSCs are able to remain in the infarcted area and make 
contact with the surrounding cardiac cells, if implanted within the injured tissues [23]. Yet, their 
ability to reach such sites after ischemia still remains unchecked. In the present study, we showed 
that dental pulp stem cells are able to migrate into damaged cardiac tissues leaving the site of 
injection, as evidenced by the co-localization of implanted cells and trypan blue stain. The 
dependence of this migration and the subsequent homing from the uninjured status of the 
myocardium was evinced by the scanty MUR-1 migration observed in the uninjured controls. 
Similarly to what occurred in-vitro, the homing of the migrated cells could be attributed to the 
organization of CX43 and N-CAD cell-cell interactions [24, 27, 28] and to the vWF-mediated 
adhesion [21, 25] via p38 MAPK [26]. Interestingly, our data show that all considered factors are 
differently localized and organized if MUR-1 cells are implanted in control or infarcted hearts. In 
Ctrl hearts, CX43 and N-CAD were mainly detected amidst MUR-1 cells, which remained close to 
each other in the injection site, thus allowing the formation of local cell clusters. On the contrary, 
in I/R hearts, both were found pinpointed between MUR-1 cells and CMs. In this case, MUR-1 cells 
did not remain clusterized in the injection site but disaggregated and migrated. In addition, CX43 
and N-CAD were generally co-localized on plasma membrane, in accord with the previous 
observation that presence of N-CAD is required for the proper assembly of CX43[28, 44, 45]. 
Although CX43 and N-CAD are involved in many cellular processes, including migration, their 
concomitant presence and localization between MUR-1 and CMs suggest the presence of both gap 
(electrical) and adherence (mechanical) junctions. Furthermore, the enhanced presence of vWF in 
ischemic tissues [46, 47] could mediate the permanence of migrated stem cells in the damaged 
area, as evinced by the localization of MUR-1 cells which were found onto or surrounded by vWF 
spots in I/R, but not in Ctrl hearts.  
Using Boyden chamber assay, we identified the possible chemotactic factors involved in MUR-1 
migration. It is known that SDF-1, FGF-2, HGF and VEGF are transiently released [29-34] after 
ischemia in order to mediate salvage and/or revascularization. We demonstrated that MUR-1 cells 
express the cognate receptors for SDF-1 (CXCR4), FGF-2 (FGFR1), HGF (c-MET) and VEGF (Flt-1, 
besides Flk-1 whose expression was previously reported [17]). MUR-1 motility depends in-vitro on 
SDF-1, FGF-2 and HGF, mimicking what occurs for neural crest cell migration during the heart 
organogenesis [24]. Indeed, the expressions of both FGF-2 and HGF are needed to promote 
gastrulation [48, 49] as well as to drive migration of cells from the neural crest [48, 50]. At this 
stage, FGF-2 mainly induces these cells to migrate towards the mandibular mesenchymal regions 
[50] thus triggering the organogenesis of cranial tissues from which MUR-1 were isolated [17]. The 
expression of FGF-8 regulates the FGF-2 localization [50] and distance-dependent gene expression 
patterning in migrating neural crest cells: the farthest and most caudal become the cardiac ones 
[24]. Conversely, VEGF can attract neural crest cells to the hyoid arch [51], but it does not further 
induce cardiac neural crest cell migration from the circumpharyngeal ridge [24]. Likewise it also 
appears not involved in MUR-1 cell migration. Finally, HGF mediates the premyocardium 
formation through the condensation of cardiac neural crest cells, and later it contributes to drive 
the whole early heart development [52], whilst SDF-1 induces their condensation around the 
aortic arch arteries [24], whose proper development is regulated by FGF-2 [30, 53]. Both HGF and 
SDF-1 expressions are needed to promote the cell commitment towards CM lineage via the 
induction of Gata4 and Mef2c transcription factors [54, 55], already expressed by MUR-1 cells 
[17]. At the same time, FGF-2 regulates myocytes proliferation and epicardial cell development 
[30]. After mesenchyme-epithelium transition epicardial-derived cells migrate into the 
myocardium, and here they stop probably in response to hypoxia-mediated Flt-1 stimulation [56]. 
In myocardium they differentiate into smooth muscle cells and cardiac fibroblasts [57], thus 
contributing to originate atrio-ventricular valves and coronary arteries [58, 59].  
In conclusion, herein we found a similarity between what happens during the heart organogenesis 
and the early migration and homing of MUR-1 cells in ischemic models. Indeed, MUR-1 migrated 
towards and within the lesion sites following SDF-1, FGF-2 and HGF signaling and made contact 
with CMs via CX43 and N-CAD, mimicking the cardiac neural crest cell behavior when they 
assemble in the developing embryo [24, 28, 60]. Although we did not evaluated the MUR-1 
homing and fate in-vivo (in terms of survival or spontaneous differentiation toward CM and/or 
endothelial lineages), our results seem to be consistent with the in-vivo experiments of Gandia 
and co-workers [61] in which dental pulp stem cells are able to improve cardiac function and 
reduce infarct size one month after the ischemic occurrence, even if they were transplanted into 
the ischemia border zone. Moreover, the MUR-1 cell behavior and cardiac homing could be 
attributed to their high positivity to c-Kit [17] as demonstrated by Ellison et al [36], who recently 
described the key-rule of c-Kit+ cardiac stem cells in the heart repair and regeneration.  
Although the problem concerning the most suitable stem/progenitor cells for heart repair is still 
open, we used MUR-1 cells not to propose a clinical application, but rather to bring some lights on 
the initial and possibly decisive contact between stem cells and injured tissues. In our opinion, 
these results could represent the first of many steps required to achieve the coveted stem cell-
mediated organ regeneration and function preservation in-vivo. 
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 Fig 1. In-vitro migration and adhesion induction of injured H9c2 feeder on MUR-1. (A) H9c2 cells 
cultured in hypoxic and/or serum-free conditions in the bottom compartment of Boyden 
chambers induce the migration of MUR-1 cells seeded in the top compartment. Negative and 
positive controls were serum-free and 30% FBS-supplemented medium, respectively. (N=6, each). 
(B) Injured H9c2 cells enhance MUR-1 adhesion. (N=48, each). The involvement of (C-D) CX43 and 
(E-F) N-CAD (red) in MUR-1 cells (green) adhesiveness is evident for both (C and E) control and (D 
and F) injured H9c2 cells. (G-H) On the contrary, vWF (red) appears predominantly localized in the 
cytoplasm of MUR-1 in (G) controls, while it appears concurring to the establishment of focal 
adhesion on (H) injured H9c2 cells. Images are representative of N=6 slides. In the box plot graphs, 
the lower and upper bars point the distance from the 10th to 90th percentile from the median, 
while the boxes range through the 25th to 75th percentile from the median. Inside the boxes, 
horizontal line indicates the median while “+” represents the mean. ** = P<0.01; *** = P<0.001. 
Nuclei are counterstained with DAPI (blue). Scale bar = 25m. 
 
Fig 2. Behavior of implanted MUR-1 cells differs between healthy and ischemic isolated hearts. 
Organ sections were reconstructed from (A) control and (B) ischemic hearts. Perimeters delineate 
the migration areas. At higher magnification green-labeled MUR-1 appeared in clusters in (C) 
control group, while they are spread in (D) the ischemic hearts. The situation is further confirmed 
by differences between the two groups in terms of (E) MUR-1 migration volume. Moreover, (F-G) 
migrating MUR-1 co-localized in ischemic hearts with damaged tissues, which are stained with the 
red-fluorescent trypan blue dye. In box plot graph, “Ctrl” and “I/R” indicate the control and the 
ischemia/reperfusion group, respectively; the lower and upper bars point the distance from the 
10th to 90th percentile from the median, while the boxes range through the 25th to 75th percentile 
from the median. Inside the boxes, horizontal line indicates the median while “+” represents the 
mean. * = P<0.05. Scale bar: A-B = 1mm; C-D-F = 100m; G = 50m. Images are representative of 
sections from N=7 control and N=8 ischemic hearts. Trypan blue stained images are representative 
of sections from N=3 ischemic hearts. 
 
Fig 3. Ischemia affects Connexin 43 and N-cadherin localizations on implanted MUR-1 cells. (A-B) 
In Control hearts, CX43 (red) predominantly localizes amidst MUR-1 cells (green) with none or very 
few junctions with the heart fibers. On the contrary, (C-E) in infarcted hearts CX43 is pinpointed 
between tissues and single MUR-1 cells, which are infiltrating the fibers: (F-G) although not always 
present, CX43 positive spots can be appreciated in a series of adjacent slices as shown in the panel 
G (arrow). (H-J) The same pattern of expression appear also evident for N-CAD (red), in both (H) 
Ctrl and (I-J) I/R hearts (as evidenced by arrows). Nuclei are counterstained with DAPI (blue). Scale 
bar: A and C = 50μm; B, D-J = 10μm. Images are representative of sections from N=7 control and 
N=5 ischemic hearts. 
 
Fig 4. Connexin 43 and N-cadherin co-localization in normal and ischemic isolated hearts. 
Implanted MUR-1 cells (green) displayed a predominantly co-localization of both CX-43 (red) and 
N-CAD (blue) along their membranes. (A) In Ctrl specimens, CX-43 is prevalently expressed amid 
MUR-1 cells, meanwhile N-CAD can be found also near host fivers. (B) Otherwise, in I/R hearts 
CX43 and N-CAD strictly co-localize to form junction between MUR-1 and injured cardiomyocytes. 
Scale bar = 10μm. Images are representative of sections from N=7 control and N=5 ischemic 
hearts. 
 
 
Fig 5. Ischemia affects von Willebrand Factor expression on implanted MUR-1 cells. In the ex-vivo 
model, (A-B) vWF (red) is not detectable in control group between MUR-1 (green) and heart 
tissues. On the contrary, it becomes evident (C-F) in injured tissues where it can co-localize with 
MUR-1 cells: by Z-stack analysis it is possible to highlight the superimposition of a (E) MUR-1 cell 
onto (F) vWF spots. Nuclei are counterstained with DAPI (blue). Scale bar: A = 25m; B-G = 10m. 
Images are representative of sections from N=7 control and N=5 ischemic hearts. 
 
 
Fig 6. MUR-1 characterization for chemotactic factor receptors expression and their activity. (A) 
MUR-1 cells express chemotactic factor receptors involved in heart organogenesis and diseases. 
CXCR4, C-X-C chemokine receptor type 4; FGFR1, Fibroblast Growth Factor Receptor 1; c-MET or 
HGFR, Hepatocyte Growth Factor Receptor; Flt-1 or VEGFR1, Vascular Endothelial Growth Factor 
Receptor 1. Nuclei are blue-stained, whereas receptor expression is highlighted in green. Scale 
bar: 1-column = 75m; 2-column = 25m. Images are representative of N=6 slides. (B) Migration 
of MUR-1 cells seeded in the top compartment of Boyden chambers after 24h incubation with 
chemotactic factors (1, SDF-1; 2, FGF-2; 3, HGF; 4, VEGF) at different concentrations in serum-free 
medium in the bottom compartment. Negative and positive controls were serum-free medium 
and 30% FBS-supplemented medium, respectively. In the box plot graphs, the lower and upper 
bars point the distance from the 10th to 90th percentile from the median, while the boxes range 
through the 25th to 75th percentile from the median. Inside the boxes, horizontal line indicates the 
median while “+” represents the mean. * = P<0.05; ** = P<0.01; *** = P<0.001. 
 
 
Table 1. Antibodies employed for immunocytochemistry analysis 
Primary Ab (clone) Host Dilution Supplier 
CX43 (C6219) Rabbit 1:200 Sigma-Aldrich 
N-CAD (3B9) Mouse 1:100 Invitrogen 
vWF (F3520) Rabbit 1:400 Sigma-Aldrich 
CXCR4 (ab2074) Rabbit 1:400 Abcam 
FGFR1 (V) Rabbit 1:100 SantaCruz Biotechnology 
c-MET (NO-23) Mouse 1:1000 M. Prat* 
Flt-1 (C-17)-G Goat 1:100 SantaCruz Biotechnology 
Secondary Ab Reactivity Dilution Supplier 
CY3-conjugate Mouse 1:1000 Sigma-Aldrich 
CY3-conjugate Rabbit 1:1000 Sigma-Aldrich 
Alexa Fluor 488 Mouse 1:300 Molecular Probes 
Alexa Fluor 488 Rabbit 1:400 Molecular Probes 
Alexa Fluor 488 Goat 1:400 Molecular Probes 
Biotin-SP-AffiniPure Mouse 1:100 Jackson ImmunoResearch 
Tertiary Ab Reactivity Dilution Supplier 
DyLight 405 Streptavidin 1:100 Molecular Probes 
* Patented: Prat, MG (2004) “Anti-HGF-r antibodies and their use” Pub.No. WO2004108766 A2.  
Abbreviations: CXCR4, fusin or SDF-1 receptor; FGFR1, fibroblast growth factor receptor 1; c-MET, 
hepatocyte growth factor receptor; Flt-1, vascular endothelial growth factor (VEGFR) -1; Flk-1, VEGFR-2; 
CX43, Connexin 43; N-CAD, N-cadherin; vWF, Von Willebrand factor. 
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